Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.infpip.2020.100061

http://scihub22266oqcxt.onion/10.1016/j.infpip.2020.100061
suck pdf from google scholar
C7162768!7162768!C7162768
unlimited free pdf from europmcC7162768    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmidC7162768
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Therapeutic management of patients with COVID-19: a systematic review #MMPMIDC7162768
  • Tobaiqy M; Qashqary M; Al-Dahery S; Mujallad A; Hershan A; Kamal M; Helmi N
  • ä-/-ä 2020[Sep]; 2 (3): 100061 PMIDC7162768show ga
  • Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was declared a global pandemic by the World Health Organization on 11th March 2020. The treatment guidelines for COVID-19 vary between countries, yet there is no approved treatment to date. Aim: To report any evidence of therapeutics used for the management of patients with COVID-19 in clinical practice since emergence of the virus. Methods: A systematic review protocol was developed based on the PRISMA statement. Articles for review were selected from Embase, Medline and Google Scholar. Readily accessible peer-reviewed, full articles in English published from 1st December 2019 to 26th March 2020 were included. The search terms included combinations of: COVID, SARS-COV-2, glucocorticoids, convalescent plasma, antiviral and antibacterial. There were no restrictions on the types of study eligible for inclusion. Results: Four hundred and forty-nine articles were identified in the literature search; of these, 41 studies were included in this review. These were clinical trials (N=3), case reports (N=7), case series (N=10), and retrospective (N=11) and prospective (N=10) observational studies. Thirty-six studies were conducted in China (88%). Corticosteroid treatment was reported most frequently (N=25), followed by lopinavir (N=21) and oseltamivir (N=16). Conclusions: This is the first systematic review to date related to medication used to treat patients with COVID-19. Only 41 studies were eligible for inclusion, most of which were conducted in China. Corticosteroid treatment was reported most frequently in the literature.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    100061 3.2 2020